Home
About Us
Products/Pipeline
Investors
Careers
Contact Us
CEO Message
On November 7, 2018, NASDAQ displayed on their billboard in New York Times Square the news of the FDA approval of Amphastar's Primatene® MIST.
Executive Management
Amphastar Milestones
Board of Directors
Milestones
Facilities
Code of Conduct
Corporate Governance
Copyright © 2023 Amphastar Pharmaceuticals, Inc.
Privacy Terms & Conditions
This site is intended for residents of the United States
